Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_assertion type Assertion NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_head.
- NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_assertion description "[The data suggested that the Cx43 and E-cadherin are reduced with NSCLC progression, and might be important biomarkers for judging the metastasis and prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_provenance.
- NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_assertion evidence source_evidence_literature NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_provenance.
- NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_assertion SIO_000772 23621211 NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_provenance.
- NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_assertion wasDerivedFrom befree-2016 NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_provenance.
- NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_assertion wasGeneratedBy ECO_0000203 NP1072588.RA4hzUlg2mJW3ANDhdrv7haZcbM-nwETyW7Gh0fOpSA80130_provenance.